Moderate riskFDA DeviceClass II

Covidien Surgipro II surgical sutures recalled over sterility risk

Covidien is recalling certain Surgipro II 5/0 sutures (model S8698GX, lot D5M3438FY) because the sterile packaging may be torn or punctured. This could allow germs into the sutures, which may lead to infection, prolonged surgery, or vision loss when used in eye surgery. No injuries have been reported.

From the FDA notice · Read the official notice ↗ · All Covidien recalls

What to do

  1. Check whether your facility or practice has model S8698GX, lot D5M3438FY in stock.
  2. Do not use affected sutures; follow your facility's recall procedures for quarantine and return.
  3. Contact Covidien or your supplier with questions about replacement or disposal.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX
Sold in
Nationwide
Made for
All ages (under 100 years)

This recall covers 5 products — see all of them.

Details

Units affected
135,875 total
Illnesses reported
None reported
Manufactured in
60 Middletown Ave, North Haven, CT, United States
Classification
Class II
Recall number
Z-2922-2026

In the FDA's words

Description
Surgipro II S8698GX SURGIPRO II BL 5/0 18 P-13 S8698GX Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery. S8698GX UDI-DI 20612479214716 Lot D5M3438FY Distribution: US Nationwide and the countries of Australia, Austria, Belgium, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Guadeloupe, Guatemala, Honduras, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Kosovo, Lebanon, Lithuania, Luxembourg, Mexico, Namibia, Netherlands, North Macedonia, Northern Ireland, Norway, Oman, Panama, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan. Affected quantity: 135,875 total
Hazard
Product may contain a perforation or tear in the sterile barrier packaging. This issue may result in biocontamination of the sterile sutures, which may lead to infection, loss of vision if in ophthalmic utilization, or prolonged surgery.

5 products in this recall

Covidien surgical sutures recalled for compromised sterile packaging

Covidien is recalling five surgical suture products, including V-Loc 90, V-Loc 180, Dermalon, Surgipro and Surgipro II, with about 135,875 units affected. The sterile packaging may have a tear or hole, which could let germs reach the sutures and cause infection, prolonged surgery, or vision loss if used in eye surgery. The recall covers the US and many other countries, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

SterilityMedical devicesSold nationwideMore from FDA Device